NOGGY JAEN: Open Payments
NPI 1457877151 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$356 in 15 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $334 · 2025 $356
Food & beverage: $356
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 3 | $84 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $50 |
| CorMedix Inc. | 2 | $48 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $32 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $31 |
| Travere Therapeutics, Inc. | 1 | $28 |
| Amgen Inc. | 1 | $26 |
| Mallinckrodt Hospital Products Inc. | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| Alexion Pharmaceuticals, Inc. | 1 | $14 |
Products named: PREVYMIS, LIVTENCITY, DEFENCATH, Kerendia, JARDIANCE, ZERBAXA, KRYSTEXXA, ACTHAR.
Industry payments across TX — which companies pay providers there.
